The Journey BeginsUpon my advanced-stage cancer diagnosis in 2004, after never missing an annual mammography appointment, I asked my team of doctors as to why my 11 years of normal mammograms did not find my cancer. I was stunned by each of their responses that my dense breast tissue, which I was unaware of, masked my cancer for years and that mammograms are limited in finding cancers in dense breasts. The nonchalant responses from my healthcare team and their refusal to disclose this “dense” information to their patients as part of their mammography report led me to travel the bumpy and unpaved road of patient advocacy and breast health. A decade of research existed at the time of my diagnosis on the limitations of mammograms in women with dense breast tissue, and more than two decades of research on the causal risk of dense breast tissue. My desire was to expose the secret of dense breast tissue, taking this information from the scientific journals to the examining room.Social media has brought together a community of breast health advocates, breast cancer survivors and healthcare providers to communicate about the many aspects of breast cancer such as prevention, risks, screening, treatments and promising research for a cure. Open 24 hours, within seconds of breast cancer survivors’ posts about side effects from treatment, decisions about surgery and their most intimate anxieties and fears, the cheerleading team of survivors, caregivers and healthcare providers intervene. My advocacy work and our immense reach through social media give me the opportunity to console a sister or brother, to offer hope to them and their families as they “live” with a breast cancer diagnosis.In the United States, breast cancer is the second leading cause of cancer deaths in women and the leading cause of premature mortality. Whether from my local community support group or through the infinite bond of social media, I have experienced much gratitude hanging out with my breast cancer friends. Not thankful for our diagnosis, but because of the fragility of cancer, we have a heightened gratitude for each day. Too many of us can check all the boxes for the prevention measures we adhered to — no smoking, maintaining a healthy weight and diet, being physically active and never missing our yearly mammography screening. Consequently, I experience grief all too often. My global connections with friends with a breast cancer diagnosis connect me with women whose cancer had metastasized upon diagnosis. Their deaths hit hard. Like the death of President Kennedy when I was in grammar school, I can recall the exact time and place when I received notice about one of my friends passing. Often the notices are through social media. Having experienced more deaths than I am prepared for, I often think of our first-responders and hospice healthcare providers, where death becomes commonplace, and wonder how they cope with their frequent grief. Many people are using social media as a way to reach out and provide support to women and families affected by breast cancer.The internet and social media have transformed our lives. It has literally opened up a global connection to those with similar interests and passions. In my focused world of patient advocacy for breast health, I meet innumerable women, fervent in their yearly breast cancer screening yet diagnosed with a missed, delayed and advanced stage cancer because of their dense breast tissue. Like me, these women never knew about the impact of dense breast tissue on the reliability of their mammogram until after their diagnosis. Our mission is to correct this fatal flaw in breast cancer screening.Through a quick internet search for information about dense breast tissue, these “strangers” quickly become my fast friends. I often kid that AreYouDense.org and AreYouDenseAdvocacy.org, the websites of our two nonprofit organizations, are akin to an online-dating service, uniting me with breast cancer patients. These patients are stunned by their later-stage cancers, in spite of never missing a mammography appointment. These encounters lead to a relationship cultivated by e-mails, texts and online messaging. Through Facebook, I remotely get introduced to their kids, grandkids and pets, often commenting on their family’s memorable moments and encouraging them as they progress with their breast cancer treatment. As with online dating, at times we advance the relationship by communicating by phone and on several occasions meet in person. These women become my extended family. Relationships, which were birthed based on our common bond of breast cancer, develop into a heartfelt friendship. News | PACS | August 09, 2019 Lake Medical Imaging Selects Infinitt for Multi-site RIS/PACS Infinitt North America will be implementing Infinitt RIS (radiology information system)/PACS (picture archiving and… read more News | Artificial Intelligence | August 13, 2019 Artificial Intelligence Could Yield More Accurate Breast Cancer Diagnoses University of California Los Angeles (UCLA) researchers have developed an artificial intelligence (AI) system that… read more Technology | Breast Biopsy Systems | July 24, 2019 Fujifilm Releases Tomosynthesis Biopsy Option for Aspire Cristalle Mammography System Fujifilm Medical Systems U.S.A. Inc. recently expanded its breast imaging solutions with the launch of its… read more Feature | Breast Imaging | October 04, 2016 | Nancy M. Cappello, Ph.D. The Manic World of Social Media and Breast Cancer: Gratitude and Grief A cancer advocate and survivor’s viewpoint on how social media has helped form relationships and awareness based on the common bond of breast cancer News | Breast Imaging | August 02, 2019 Volpara to Distribute Screenpoint Medical’s Transpara AI Solution Volpara Solutions and ScreenPoint Medical BV signed an agreement under which Volpara will sell ScreenPoint’s Transpara… read more Image courtesy of Imago Systems News | Mammography Reporting Software | July 26, 2019 Ikonopedia Releases Automated Combined Reporting Package at AHRA Ikonopedia showcased its recently released Automated Combined Reporting package and its entire suite of structured… read more Technology | Artificial Intelligence | July 18, 2019 Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded… read more News | Ultrasound Women’s Health | July 11, 2019 FDA Clears Koios DS Breast 2.0 AI-based Software Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA). Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev AI Models Predict Breast Cancer With Radiologist-level Accuracy Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer… read more 123PreviousNext Technology | Mammography Reporting Software | July 25, 2019 Hologic Partners With MagView to Develop Unifi EQUIP Solution Hologic announced a partnership with mammography information solutions provider MagView to develop Unifi EQUIP, an… read more IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology. News | Mammography | August 14, 2019 Imago Systems Announces Collaboration With Mayo Clinic for Breast Imaging Image visualization company Imago Systems announced it has signed a know-how license with Mayo Clinic. The multi-year… read more Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire. Editor’s note: You can hear more about Cappello’s journey and her fight for awareness in the video interview “Breast Cancer Awareness” that can be found at http://bit.ly/1P0mKwp.Nancy M. Cappello, Ph.D., is director and founder of Are You Dense, Inc. and Are You Dense Advocacy, Inc., with a mission to educate the public about the risks and screening challenges of dense breast tissue to prevent missed, delayed and advanced-stage cancer, thus reducing mortality. She was the inspiration behind Connecticut’s first-in-the-nation density reporting law passed in 2009, making the state a global leader in density reporting, adjunct screening and the density reporting grassroots movement. Twenty-eight states have since enacted density reporting laws, and a federal bill is pending. FacebookTwitterLinkedInPrint分享 Related Content read more The Advocacy ContinuesThe lives and deaths of my extended newfound family motivate me as I advocate for our mission to eliminate grief of a loved one dying prematurely from this disease. The complexity of breast cancer biology tells us that even with an early diagnosis, the disease can progress and kill. However, research also concludes that early detection still matters. Tumor size and nodal status still have a significant and major influence, independent of tumor biology, in the current era of more conservative surgery and more effective systemic adjuvant therapies. While my heart and soul grieve from the death of friends from breast cancer, it also motivates me to continue to advocate for density reporting and education and access to multimodal screening to reduce advanced disease and premature death from breast cancer.